Product Information

FENOFIBRATE 67 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.0934 per EA under NDC 62135089390. Its NADAC has been published 102 times since Dec 4, 2024.

FDA first approved this application on Jan 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FENOFIBRATE 67 MG CAPSULE

fenofibrate
$0.0934per EA

Strength

67 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135089390

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FENOFIBRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211407

FDA Approved

1/31/2024

TE Code

AB

On Market Since

1/31/2024

Price Statistics

The NADAC for FENOFIBRATE 67 MG CAPSULE has been published 102 times since Dec 4, 2024, and over the history we have for it it has risen 41.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0934 per EA
All-time high$0.0934 (Nov 11, 2026)
All-time low$0.0662 (Dec 4, 2024)
52-week high$0.0934
52-week low$0.0783
Median price$0.0861
Average price$0.0852
Largest weekly change+11.1% (Dec 18, 2024)
Weeks tracked102
Tracking sinceDec 4, 2024

Price History

1W

0.0%

1M

+1.5%

3M

+0.3%

6M

+19.2%

1Y

+5.8%

3Y

N/A

5Y

N/A

All

+41.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FENOFIBRATE 67 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 67 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.0934 per EA (NDC 62135089390), effective Nov 11, 2026.

How has the price of FENOFIBRATE 67 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FENOFIBRATE 67 MG CAPSULE has risen 41.0%. It has been tracked across 102 weekly CMS publications since Dec 4, 2024.

What are the highest and lowest recorded NADAC prices for FENOFIBRATE 67 MG CAPSULE?

Since Dec 4, 2024, the NADAC for FENOFIBRATE 67 MG CAPSULE has ranged from a low of $0.0662 (Dec 4, 2024) to a high of $0.0934 (Nov 11, 2026), with a median of $0.0861 per EA.

Are there cheaper alternatives to FENOFIBRATE 67 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 67 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures FENOFIBRATE 67 MG CAPSULE?

FENOFIBRATE 67 MG CAPSULE (NDC 62135089390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.